Baseline hematological parameters and outcomes in patients with prostate cancer treated with Lu-177 PSMA radioligand therapy (RLT): A multicenter real-world analysis.

Authors: Colin P. Bergstrom, Joseph David Allen, Cameron Chalker, Hong Song, Alexandra Sokolova, Ali Raza Khaki

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e17047

Source: Full article


Abstract

e17047